Renaissance Technologies’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-57,650
Closed -$166K 3685
2024
Q4
$166K Buy
57,650
+17,800
+45% +$51.2K ﹤0.01% 3211
2024
Q3
$102K Sell
39,850
-57,820
-59% -$149K ﹤0.01% 3251
2024
Q2
$191K Sell
97,670
-16,800
-15% -$32.9K ﹤0.01% 3055
2024
Q1
$304K Buy
114,470
+100,020
+692% +$266K ﹤0.01% 3086
2023
Q4
$60K Buy
+14,450
New +$60K ﹤0.01% 3419
2023
Q2
Sell
-45,520
Closed -$155K 4113
2023
Q1
$155K Sell
45,520
-47,050
-51% -$160K ﹤0.01% 3363
2022
Q4
$417K Buy
92,570
+53,440
+137% +$241K ﹤0.01% 3052
2022
Q3
$344K Sell
39,130
-22,952
-37% -$202K ﹤0.01% 3138
2022
Q2
$714K Buy
+62,082
New +$714K ﹤0.01% 2926
2022
Q1
Sell
-5,950
Closed -$193K 4309
2021
Q4
$193K Sell
5,950
-91,370
-94% -$2.96M ﹤0.01% 3521
2021
Q3
$3.9M Buy
97,320
+79,191
+437% +$3.18M 0.01% 1615
2021
Q2
$297K Buy
18,129
+15,069
+492% +$247K ﹤0.01% 3151
2021
Q1
$58K Sell
3,060
-29,990
-91% -$568K ﹤0.01% 3243
2020
Q4
$744K Sell
33,050
-36,820
-53% -$829K ﹤0.01% 2645
2020
Q3
$1.38M Buy
69,870
+22,120
+46% +$438K ﹤0.01% 2325
2020
Q2
$998K Buy
47,750
+30,470
+176% +$637K ﹤0.01% 2539
2020
Q1
$273K Buy
+17,280
New +$273K ﹤0.01% 3011
2019
Q1
Sell
-16,291
Closed -$326K 3592
2018
Q4
$326K Buy
16,291
+2,404
+17% +$48.1K ﹤0.01% 3001
2018
Q3
$1.08M Buy
13,887
+2,640
+23% +$206K ﹤0.01% 2574
2018
Q2
$1.01M Buy
11,247
+2,225
+25% +$200K ﹤0.01% 2593
2018
Q1
$749K Buy
+9,022
New +$749K ﹤0.01% 2775
2017
Q3
Sell
-2,795
Closed -$184K 3289
2017
Q2
$184K Sell
2,795
-1,750
-39% -$115K ﹤0.01% 3009
2017
Q1
$417K Buy
+4,545
New +$417K ﹤0.01% 2822